METASTATIC GASTRIC ADENOCARCINOMA
Clinical trials for METASTATIC GASTRIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC GASTRIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC GASTRIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Stomach cancer drug combo fails to shrink tumors in small trial
Disease control OngoingThis study tested a combination of two drugs, berzosertib and irinotecan, in 17 people with advanced stomach or gastroesophageal junction cancer that had a specific genetic change (TP53 mutation). The goal was to see if the combination could shrink tumors. Unfortunately, no patie…
Matched conditions: METASTATIC GASTRIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 04:17 UTC
-
Radiation boosts chemo for stomach and esophageal cancer?
Disease control OngoingThis study tests whether adding radiation therapy to standard chemotherapy helps people with HER2-negative esophageal or stomach cancer that has spread to a few other spots in the body (oligometastatic). About 314 participants will receive either chemotherapy alone or chemotherap…
Matched conditions: METASTATIC GASTRIC ADENOCARCINOMA
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 26, 2026 03:56 UTC
-
Experimental combo targets Hard-to-Treat cancers
Disease control OngoingThis early-phase trial tests the safety and best dose of sonidegib combined with the immunotherapy pembrolizumab in people with advanced solid tumors that have spread. The goal is to see if this drug pair can shrink tumors or slow their growth. About 36 adults with cancers like m…
Matched conditions: METASTATIC GASTRIC ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 03:55 UTC
-
New way to deliver chemotherapy shows promise for stomach cancer patients
Disease control OngoingThis early-phase trial is testing the safety and best dose of the chemotherapy drug paclitaxel when given directly into the abdomen (intraperitoneal) for people with advanced stomach or gastroesophageal cancer that has spread to the lining of the abdomen. The study includes 27 pa…
Matched conditions: METASTATIC GASTRIC ADENOCARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:50 UTC